A key drug is at the center of a court case. This drug is used in a common abortion procedure. Judges are considering whether rules for prescribing this drug should be more strict. The case is part of a larger effort to restrict abortion access.

The US Food and Drug Administration is also reviewing its rules and may make changes. This agency review could impact the court's decision.

Further details about the case and its potential implications are available from the source.